[1] 季霄雷, 郭陈, 陈璐, 等. 2020-2021年南通地区急性病毒性胃肠炎疫情中诺如病毒分子分型分析[J].病毒学报, 2022, 38(4):841-849. [2] 易中恒, 杨俊杰, 李薇. 诺如病毒感染的疾病负担及防治[J].微生物学免疫学进展, 2022, 50(3):98-103. [3] HE T, MCMILLEN TA, QIU Y,et al.Norovirus loads in stool specimens of cancer patients with norovirus gastroenteritis[J]. J Mol Diagn, 2017, 19(6):836-842. [4] GE L, CHEN X, LIU J,et al.Genomic and biological characterization of a pandemic norovirus variant GII.4 Sydney 2012[J]. Virus Genes,2020, 56(2):144-181. [5] 王林平, 高珺珊, 薛亮, 等. 广州地区GII.4 Sydney 2012[P31]型诺如病毒GZ2013-L10毒株病毒样颗粒功能和免疫原性鉴定[J].微生物学通报, 2022, 49(6):2256-2265. [6] ROLFES MC, SRIAROON P, DÁVILA SALDAÑA BJ,et al.Chronic norovirus infection in primary immune deficiency disorders: an international case series[J]. Diagn Microbiol Infect Dis, 2019, 93(1):69-73. [7] NORDGREN J, SVENSSON L.Genetic susceptibility to human norovirus infection: an update[J]. Viruses, 2019, 11(3):226. [8] HUYNEN P, MAUROY A, MELIN PM,et al.Noroviruses, these unknown worldwide epidemic enteropathogens[J]. Rev Med Liege,2019, 74(1):41. [9] DEGIUSEPPE JI, BARCLAY L, GOMES K,et al.Molecular epidemiology of norovirus outbreaks in Argentina, 2013-2018[J]. J Med Virol,2020, 92(8):1330-1333. [10] LI B, XIAO D, LI Y,et al.Epidemiological analysis of norovirus infectious diarrhea outbreaks in Chongqing, China, from 2011 to 2016[J]. J Infect Public Health,2020, 13(1):46-50. [11] GRAU KR, ROTH AN, ZHU S,et al.The major targets of acute norovirus infection are immune cells in the gut-associated lymphoid tissue[J]. Nat Microbiol,2017, 2(12):1586-1591. [12] SERENARI M, HAN K, RAVAIOLI F,et al.A nomogram based on liver sti ness predicts postoperative complications in patients with hepatocellular carcinoma[J]. J Hepatol, 2020, 73(4):855-862. [13] TANG Y, ZHANG T, ZHAO Y,et al.Development and validation of a comprehensive radiomics nomogram for prognostic prediction of primary hepatic sarcomatoid carcinoma after surgical resection[J]. Int J Med Sci, 2021, 18(7):1711-1720. [14] HE W, LIU X.Significance of peripheral blood indexes in differential diagnoses of SARS-CoV-2 and New Bunia virus[J]. Sci Rep, 2021, 11(1):14094. [15] NORDGREN J, SVENSSON L.Genetic Susceptibility to Human Norovirus Infection: An Update[J]. Viruses, 2019, 11(3):226. [16] CARDEMIL CV, PARASHAR UD, HALL AJ.Norovirus Infection in Older Adults: Epidemiology, Risk Factors, and Opportunities for Prevention and Control[J]. Infect Dis Clin North Am, 2017, 31(4):839-870. [17] CATES JE, VINJÉ J, PARASHAR U, et al.Recent advances in human norovirus research and implications for candidate vaccines[J]. Expert Rev Vaccines, 2020, 19(6):539-548. [18] TORÉN K, SCHIÖLER L, NENONEN NP, et al. Risk factors for norovirus infection in healthcare workers during nosocomial outbreaks: a cross-sectional study[J]. Antimicrob Resist Infect Control, 2021, 10(1):107. [19] KHAN MK, ALAM MM. Norovirus Gastroenteritis Outbreaks, Genomic Diversity and Evolution: An Overview[J]. Mymensingh Med J,2021, 30(3):863-873. [20] WILLIAMS AM, LADVA CN, LEON JS, et al.Changes in micronutrient and inflammation serum biomarker concentrations after a norovirus human challenge[J]. Am J Clin Nutr, 2019, 110(6):1456-1464. [21] BROCARD M, LU J, HALL B, et al.Murine Norovirus Infection Results in Anti-inflammatory Response Downstream of Amino Acid Depletion in Macrophages[J]. J Virol, 2021, 95(20):e0113421. |